Methods, uses, compositions, combinations and kits relating to the decrease of Tau protein levels, and prevention and/or treatment of diseases or disorders associated with Tau protein (Tauophathies), such as Alzheimers disease, using a curcuminoid and a mammalian target rapamycin (mTOR) inhibitor, are described.